Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
NanoViricides logo

NanoViricides

Recent Finacing

Post-IPO Equity

Recent Raise

$6M

NanoViricides is a Shelton-based biotech developing a broad-spectrum antiviral nanomedicine platform, with lead candidate NV-387 aimed at mpox and other viral diseases.

Connecticut, United States
1-10
Publicly Traded
nanoviricides.com
PitchBook

Highlights

Focus Areas

Biopharma
Biotechnology
Medical

Financials

$6M

Total Raised

1

Funding round


Team

Upgrade to view the team

See the team members at NanoViricides.